Quantitative structure-cytotoxicity relationship of 3-styrylchromones

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Pharmacology

Background:

• Fifteen 3-styrylchromone derivatives were investigated for their biological activities, including cytotoxicity, tumor selectivity, and anti-HIV potential.
• Understanding structure-activity relationships is crucial for developing targeted therapies.

Purpose of the Study:

• To perform a quantitative structure-activity relationship (QSAR) analysis on 3-styrylchromones.
• To explore the cytotoxicity, tumor selectivity, and anti-HIV activity of these compounds.
• To identify key molecular descriptors influencing their biological effects.

Main Methods:

• Cytotoxicity was assessed using the MTT assay against oral squamous cell carcinoma (OSCC) and normal oral cell lines.
• Tumor selectivity was calculated as the ratio of cytotoxic concentrations (CC50) in normal versus cancer cells.
• Anti-HIV activity was determined by comparing CC50 to the 50% effective concentration (EC50).
• Molecular conformations were optimized using LowModeMD and DFT methods for physicochemical and quantum-chemical parameter calculations.

Main Results:

• All tested 3-styrylchromone derivatives exhibited moderate to high tumor selectivity.
• Compounds with a 6-methoxy group on the chromone ring and a 4'-hydroxyl group on the phenyl moiety demonstrated the highest tumor selectivity.
• Cytotoxicity against normal cells correlated with descriptors related to hydrophobic interactions and molecular shape.

Conclusions:

• Multivariate statistical analysis incorporating chemical descriptors for substituent location, molecular shape, and electrostatic interactions can guide the design of potent compounds.
• This approach aids in optimizing compounds for enhanced tumor selectivity.
• The findings provide a basis for the rational design of novel 3-styrylchromone derivatives with improved therapeutic potential.